[Question] triple agonist — what am I missing here
Trying to get a straight answer on this: triple agonist — what am I missing here. Watched heart rate on a wearable across twelve weeks because the threads said to. It moved a little and I have no idea whether that means anything. Sent a vial to Medutest out of curiosity. Result was 99.6% against a claimed 99.0%,…
The standing caveat, written out properly because it keeps getting compressed into a footnote.
Nothing containing this compound is approved by any regulator. Research-use-only material is not approved for human use. That is not a legal formality on this board — it is why there is so little independent data, why the escalation schedules people post are invented, and why nobody here can answer a dosing question.
What this board can usefully do is read the published trials carefully, log independent purity results, and be honest about how thin the evidence base is. Everything else belongs somewhere with a clinician in it.
Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.
Which phase 2 arm are you quoting, and at what week?
Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.
Small fix — three receptors, not two.
Adding the standing caveat: none of this is approved anywhere and research material is not for human use.
the glucagon component is why the metabolic story reads differently
not approved anywhere, which is the single most important fact in this board
Are you tracking heart rate at all?
research-use-only material is not approved for human use, full stop